Primary |
Contraception |
39.7% |
Product Used For Unknown Indication |
10.7% |
Acne |
10.3% |
Menstrual Cycle Management |
4.9% |
Menstruation Irregular |
4.5% |
Pain |
4.3% |
Premenstrual Syndrome |
4.3% |
Menorrhagia |
2.7% |
Oral Contraception |
2.5% |
Polycystic Ovaries |
2.5% |
Ovarian Cyst |
2.2% |
Premenstrual Dysphoric Disorder |
1.7% |
Depression |
1.4% |
Medical Diet |
1.4% |
Endometriosis |
1.3% |
Headache |
1.3% |
Hypothyroidism |
1.1% |
Sinusitis |
1.1% |
Hormone Level Abnormal |
1.0% |
Menstrual Disorder |
1.0% |
|
Pulmonary Embolism |
22.4% |
No Adverse Event |
14.3% |
Metrorrhagia |
6.6% |
Deep Vein Thrombosis |
6.0% |
Vaginal Haemorrhage |
5.3% |
Drug Dose Omission |
4.9% |
Menstruation Delayed |
4.5% |
Thrombosis |
3.6% |
Acne |
3.4% |
Menorrhagia |
3.4% |
Pain |
3.2% |
Vomiting |
2.9% |
Headache |
2.8% |
Off Label Use |
2.8% |
Hypomenorrhoea |
2.4% |
Polymenorrhoea |
2.4% |
Pregnancy On Oral Contraceptive |
2.4% |
Thrombophlebitis Superficial |
2.4% |
Nausea |
2.3% |
Amenorrhoea |
1.9% |
|
Secondary |
Contraception |
27.8% |
Acne |
13.0% |
Premenstrual Syndrome |
11.0% |
Pain |
6.4% |
Menstrual Cycle Management |
5.0% |
Polycystic Ovaries |
4.5% |
Menstruation Irregular |
4.0% |
Anxiety |
3.8% |
Supplementation Therapy |
3.0% |
Premenstrual Dysphoric Disorder |
2.5% |
Menorrhagia |
2.3% |
Menstrual Disorder |
2.2% |
Dysmenorrhoea |
2.0% |
Ovarian Cyst |
2.0% |
Depression |
1.8% |
Headache |
1.8% |
Gastrooesophageal Reflux Disease |
1.7% |
Hormone Level Abnormal |
1.7% |
Hypothyroidism |
1.7% |
Migraine |
1.7% |
|
Pulmonary Embolism |
36.9% |
Pain |
12.0% |
Deep Vein Thrombosis |
7.2% |
Psychological Trauma |
6.4% |
Thrombosis |
5.6% |
Thrombophlebitis Superficial |
4.8% |
Metrorrhagia |
3.6% |
Pulmonary Infarction |
2.8% |
Menorrhagia |
2.4% |
Vaginal Haemorrhage |
2.4% |
No Adverse Event |
2.0% |
Chest Pain |
1.6% |
Emotional Distress |
1.6% |
Menstruation Delayed |
1.6% |
Pain In Extremity |
1.6% |
Pulmonary Thrombosis |
1.6% |
Syncope |
1.6% |
Vena Cava Thrombosis |
1.6% |
Anxiety |
1.2% |
Injury |
1.2% |
|
Concomitant |
Product Used For Unknown Indication |
29.8% |
Contraception |
16.7% |
Post Coital Contraception |
14.3% |
Crohn's Disease |
9.5% |
Acne |
3.6% |
Inflammatory Bowel Disease |
3.6% |
Insomnia |
2.4% |
Menstrual Cycle Management |
2.4% |
Premedication |
2.4% |
Premenstrual Syndrome |
2.4% |
Seasonal Allergy |
2.4% |
Asthma |
1.2% |
Asthma Exercise Induced |
1.2% |
Dental Care |
1.2% |
Endometriosis |
1.2% |
Hormone Level Abnormal |
1.2% |
Inflammation |
1.2% |
Multiple Sclerosis |
1.2% |
Narcolepsy |
1.2% |
Oral Contraception |
1.2% |
|
Menstruation Irregular |
17.2% |
Pelvic Pain |
17.2% |
Pharyngeal Oedema |
6.9% |
Arthralgia |
3.4% |
Constipation |
3.4% |
Dizziness |
3.4% |
Drug Dose Omission |
3.4% |
Fear |
3.4% |
Flushing |
3.4% |
Headache |
3.4% |
Hypogeusia |
3.4% |
Infectious Mononucleosis |
3.4% |
Injection Site Reaction |
3.4% |
Menstruation Delayed |
3.4% |
Nightmare |
3.4% |
Pyrexia |
3.4% |
Toxicity To Various Agents |
3.4% |
Transient Ischaemic Attack |
3.4% |
Urinary Tract Infection |
3.4% |
Weight Increased |
3.4% |
|